Rating History
Dissemination Date Long-Term Rating Short-Term Rating Outlook Action Rating Watch
15-May-26 A+ A1 Stable Maintain -
16-May-25 A+ A1 Stable Maintain -
17-May-24 A+ A1 Stable Maintain -
17-May-23 A+ A1 Stable Maintain -
17-May-22 A+ A1 Stable Upgrade -
About the Entity

Descon Oxychem Limited (DOL), incorporated in 2004, commenced commercial production of Hydrogen Peroxide in March 2009. Descon Group, the principal sponsor of Descon Oxychem, holds a majority shareholding of 72.63% through associated companies, while a 27.37% stake is held by financial institutions and the general public. Descon Group has a strong foothold in the engineering business through its flagship company, Descon Engineering Limited. The Company’s Board, comprising eight members, is dominated by representatives of Descon Group. Mr. Faisal Dawood is the Chairman of the Board, while Mr. Yasir Siddique Sheikh is the CEO of the Company.

Rating Rationale

Descon Oxychem Limited (‘DOL’ or ‘the Company’), a listed concern, primarily engaged in the manufacturing, procurement, and sale of Hydrogen Peroxide (HPO) & allied products. Offering Technical, Aseptic, and Food Grades in different concentrations, DOL’s diverse HPO applications span key sectors including textile, mining, pulp & paper, water treatment, sugar, food & beverages, cosmetics, and poultry. The Company’s leading market position is supported by strong sponsorship and established client relationships. Notably, its sustainable, non-chlorine-based food-grade HPO offers substantial growth prospects within the food sector, requiring focused strategic development. Pakistan’s HPO market has transitioned from a monopoly to a two-player structure following Engro Polymer’s commissioning of a ~28,000 MT (50% concentration basis) plant in March 2025. Combined domestic production now covers ~60% of the total estimated demand of ~100,000 MT (50% concentration basis), with the remainder continuing to be met through imports. Engro’s incremental volumes have thus far largely displaced import share rather than directly eroding DOL’s domestic offtake. Imports, however, remain the most acute competitive threat, particularly from Bangladesh, whose structural cost advantages are further amplified by export schemes, which effectively subsidize import procurement and render import-origin HPO artificially cost-competitive against domestically produced volumes. During 9MFY26, DOL’s net revenues declined year-over-year, primarily driven by pricing pressure amid an influx of lower-priced imports, while volumetric performance remained broadly stable with near-full capacity utilization. Export revenues showed a gradual improvement, supported by the Company’s expanding international presence through its UAE subsidiary. Profitability metrics came under pressure during the period, reflecting a combination of industry-wide price erosion and elevated energy costs. Margins moderated across the board, as cost pressures outpaced pricing flexibility. To partially offset these pressures, the commissioning of a 2 MW solar power project is expected to provide energy cost savings, offering some relief given the share of power costs in the overall cost. The Company’s financial risk profile remains good, supported by strong coverage metrics, moderate cash generation, and a manageable working capital cycle. DOL’s capital structure is moderately leveraged, comprising a mix of long-term and short-term borrowings supported by a solid equity base. Going forward, DOL’s strategic move focuses on deepening penetration in higher-margin segments, expanding its export channel, and pursuing further cost optimization through energy efficiency and process improvements.

Key Rating Drivers

The ratings are dependent on DOL’s ability to sustain its market position amid intensifying competition and persistent import-driven pricing pressures. A recovery in selling prices, normalization of import cost distortions, and successful execution of the Company’s strategy to deepen penetration in higher-margin segments and expand its export channel shall remain critical. Maintenance of adequate cashflow, working capital cycle, and a prudent business risk profile will be equally imperative.

Profile
Legal Structure

Descon Oxychem Limited (hereinafter referred to as “DOL” or “the Company”) is a public listed entity incorporated under the Companies Ordinance, 1984 (now “Companies Act, 2017”). Its registered office is located at 18-KM Ferozepur Road, Lahore. DOL has free float shares of 30% as of May 2026. The share price remained between ~PKR 25.37 and ~PKR 28.84 during the period under review.


Background

Descon Oxychem was incorporated as a private limited company in 2004 and was listed on September 15, 2008. It is a project of the Descon Group. The Company is a subsidiary of DEL Chemicals (Private) Limited (the parent company), an unlisted private company incorporated in Pakistan. Following commissioning in October 2008, the Company’s plant started commercial production in March 2009. The Company has also incorporated a wholly owned subsidiary, “Descon Oxychem FZE,” in the Hamriyah Free Zone, Sharjah, UAE, that is engaged in the import, export, and trade of chemicals & related products, detergents & disinfectants, water treatment & purification chemicals, and raw materials.


Operations

The prime business of Descon Oxychem is the manufacturing & distribution of Hydrogen Peroxide (HPO) of up to 60% concentration. Descon Oxychem has launched its brands for different grades of Hydrogen Peroxide with different concentration levels including: i) Technical Grade, ii) Aseptic Grade, and iii) Food Grade. Product mix remains concentrated in technical-grade HPO; Food Grade contributes a relatively small revenue share despite its higher margin profile, limiting near-term earnings diversification. DOL’s production facility is located at 18-KM Lahore Sheikhupura Road, consisting of an HPO plant and a Hydrogen plant. The Hydrogen plant, is capable of producing hydrogen sufficient for two-fold expansion of HPO facility. Descon Oxychem has technical collaboration with Chematur Engineering Sweden, a well-known engineering firm that has delivered more than 1,100 different chemical industrial plants worldwide. It has provided detailed engineering for construction of HPO plant to Descon Engineering Limited (Flagship Company of the Descon Group) and assisted in the plant’s commissioning. The Company’s installed capacity of HPO stands at ~42,000 MT per annum at 100% concentration (~21,000 MT per annum at 50% basis). In FY25, Descon Oxychem achieved production of ~42,420 MT, and continued near-full utilization in 6MFY26 with 21,329 MT produced, indicating that the volume base has remained broadly intact.



Ownership
Ownership Structure

The principal sponsor of Descon Oxychem holds a majority shareholding of ~72.63% through associated companies while the remaining ~27.37% stake rests with the financial institutions and the general public.


Stability

The transfer of the Company's ownership to a holding company provides clarity to Descon Oxychem’s ownership structure, boding well for its stability.


Business Acumen

Originating from Pakistan, the Descon Group has, over the years, expanded its horizons to Abu Dhabi, Saudi Arabia, Qatar, Oman and Egypt. With presence in the chemical sector since 1980, Descon Oxychem is well placed to benefit from the Group’s technical knowledge, vast distribution network and established relationship with clients. Mr. Abdul Razak Dawood, former Advisor to Ex-Prime Minister Imran Khan for Commerce, Textile, Industry and Production of Pakistan, was founder and former Chairman of the Descon Group. Now, Mr. Taimur Dawood, son of Mr. Abdul Razak Dawood, leads the Group. The Dawoods are one of the well-known business families of the country and known for their business acumen.


Financial Strength

Descon Group has expanded its footing in diversified business avenues with a sizable portfolio of strategic investments, enhancing the Group’s financial strength. Its business portfolio spans across various sectors including engineering, power and chemicals. The Group aims for sustainable profitability of its business ventures while expanding its outreach globally through timely exploitation of business opportunities. The Group has shown willingness and ability to support the Group companies in times of need.


Governance
Board Structure

The Company’s board comprises eight members including five non-executive, two independent directors, and one executive who also serves as the CEO. Descon Oxychem's board structure is considered strong.


Members’ Profile

Descon Oxychem’s board comprises highly qualified members and has a blend of business studies, engineering, and finance professionals. The Chairman, Mr. Faisal Dawood holds a Bachelors degree in Materials Science and Engineering from Cornwell University and an MBA from Columbia University. He has served at multiple management positions within the engineering and chemical divisions of the Descon Group and currently also serves as the Vice-Chairman of Descon Engineering. Furthermore, Mr. Taimur Dawood has over 20 years of diversified experience in engineering, product marketing, project finance, strategy development and implementation and mergers and acquisitions. He is serving as Chairman of other Descon Group companies including Descon Engineering Limited and Descon Power Solutions (Pvt.) Limited. He is also the Managing Director of Gray Mackenzie Engineering Services BV, the Netherlands. From 2001 to 2011, Mr. Taimur served as the CEO of Descon Chemicals. The other directors of the Company hold senior positions in associated companies and serve on the Boards of other Group companies. They further strengthen the Board with their diverse professional backgrounds and extensive expertise.


Board Effectiveness

Meeting agendas provided to Board members and documentation of meeting minutes remain strong. The Board further ensures effective governance through four committees, namely: i) Enterprise Risk Management Committee, ii) Audit Committee, iii) Human Resource & Remuneration Committee and iv) Compliance Committee. The Audit Committee is chaired by a non-executive Director. The Board also ensures strong monitoring and control through monthly meetings with management – conducted by nominated Board members. Prior to this meeting, MIS reports are sent to all Board members and a thorough discussion is held on key performance areas. This bodes well for the Board’s effectiveness.


Financial Transparency

M/s Crowe Hussain Chaudhury & Co., listed in Category “A” of the State Bank’s panel of auditors, is the external auditor of the Company. The auditors have reviewed the Company’s financial statements for the period ended March 30, 2026. Meanwhile, public disclosures remain strong. The Company has outsourced its internal audit function to KPMG Taseer Hadi & Co., also listed in Category “A” of the State Bank’s panel of auditors.


Management
Organizational Structure

The Company operates through seven functional departments, each headed by an experienced manager. The departments include: i) Plant Management, ii) Investments, iii) Marketing & Sales – North & South, iv) Finance & Accounts, v) Human Resource, vi) Quality & Assurance and vii) Sourcing & Planning. All departmentheads/managers’ report directly to the CEO. In order to rationalize costs some business functions (IT, HR and Accounting & Finance) are shared at Group level. Currently, all key positions within the organization are fully staffed, reflecting the Company’s commitment to maintaining a robust and efficient workforce.


Management Team

Mr. Yasir Siddique Sheikh is currently serving as the CEO of Descon Oxychem, appointed in 2025. He is a seasoned business leader with over two decades of experience across engineering, finance, and technology, currently serving as CEO of Descon Oxychem Limited. He previously held senior roles at Descon Engineering, including CFO and Head of Functional Services, where he drove financial optimization and integrated core functions to support growth. His earlier experience includes corporate banking roles at HSBC and HBL, and a start in software engineering at Techlogix. He holds an MBA and a B.Sc. (Hons.) in Computer Science from LUMS and brings a strong focus on value creation and sustainable growth. He is assisted by a team of experienced and seasoned professionals, including the CFO, Ms. Rabia Shoaib, a qualified Chartered Accountant, who joined the Descon Group in 2022. With over 18 years of experience across multiple finance domains, she brings expertise in project control, stakeholder management, and financial operations.


Effectiveness

Descon Oxychem’s senior management receives daily performance reports of the plant’s operations which results in optimal monitoring. While there are no formal management committees, key management personnel meet on daily and weekly basis to discuss key issues. Furthermore, there are regular need-based meetings for discussion of issues.


MIS

The Company has implemented R12 version of the Oracle E-business suite application, which is also used at other associated companies of Descon. The ERP solution is capable of generating various MIS related to production, inventory management, sales and trade receivables/payables. Oracle Financials, Manufacturing and Projects modules have been completely implemented. The implementation of the ERP system further strengthens the control environment of the Company due to in-built controls of the system, in addition to better reporting and increased efficiency due to automation of the business processes.


Control Environment

Years back, the Hydrogen peroxide (H2O2) as a relatively new product for the domestic chemical sector and owing to the initial setup arrangements with Chematur Engineering, Sweden; the technical specifications of Descon Oxychem’s plant appear sound. Regular visits by Chematur’s staff also ensure efficient capacity utilization and quality of final product. Descon Oxychem has been given the license to be sole operator of Chematur technology in Pakistan. The plant is highly automated and is operated by DCS (Digital Control System). It assists management in controlling and monitoring the production process and chemical levels. To improve operational reliability Descon Oxychem has built organizational capacity by implementing Quality hygiene Safety Model and Reliability Centre Management. Introduction of Reliability Centre Management has changed the perspective of Company’s operation from ‘fix it’ culture to ‘run it’ culture. This culture has helped Descon Oxychem to improve plant reliability significantly.


Business Risk
Industry Dynamics

Pakistan’s HPO sector operates within a globally oversupplied commodity market, with worldwide demand of ~5.5–6.0mln MT (100% concentration basis) growing at 3–4% annually. China’s capacity exceeding 3.0mln MT sustains a structural surplus, keeping global prices suppressed and transmitting persistent downward pricing pressure to import-competitive markets such as Pakistan. Domestically, the market has transitioned from a monopoly to a two-player structure following Engro’s commissioning of a ~28,000 MT (50% concentration basis) plant in March 2025. Total domestic demand stands at ~100,000 MT (50% basis) under normal circumstances, with combined domestic supply now nearing full coverage. Geographically, the two players are structurally differentiated: Descon’s plant in central Punjab provides proximity to the country’s core textile manufacturing clusters, supporting lower inland freight costs and stronger customer integration, while Engro’s southern location offers logistical proximity to port infrastructure, favouring cost efficiencies in import substitution and southern market access. This freight differential defines the primary competitive boundary between the two producers. Beyond the technical-grade segment, Descon retains a relative advantage in higher-margin Aseptic and Food Grade segments, where product quality requirements and customer specifications limit substitutability.

Imports represent the most critical and continuous competitive threat facing domestic producers. Bangladesh has emerged as a particularly disruptive source, with structurally lower energy costs, efficient port logistics, and a lean manufacturing base enabling HPO supply at landed costs that approach or undercut domestic variable cost levels. This cost advantage is materially amplified by Pakistan's Export Finance Scheme (EFS), which allows importers to access concessional financing, effectively subsidising import procurement and further compressing the price at which foreign HPO enters the domestic market. The combined effect renders import-origin HPO artificially cost-competitive against domestically produced volumes, disproportionately pressuring margins in the technical-grade segment. While anti-dumping duties offer some origin-specific protection, their scope remains narrow and fails to address the systemic pricing distortion introduced by EFS, leaving domestic producers structurally exposed to below-cost import competition.

Near-term pricing showed some recovery toward end-March 2026, as geopolitical disruptions in the Middle East caused temporary shipping delays and cost escalations for importers. This relief although not structural; however, remains contingent on geopolitical conditions because any easing of shipping disruptions could reverse this headroom rapidly. Over the medium term, sector dynamics are expected to gradually improve, supported by the NTC’s engagement on anti-dumping mechanisms, potential tightening of EFS applicability to chemical imports, and Sitara Peroxide’s continued absence from the market. Domestic demand is projected to grow at 5–7% per annum, driven by textile sector expansion and incremental HPO adoption in paper, food, and wastewater treatment applications.


Relative Position

Descon Oxychem remains Pakistan’s largest HPO producer with ~42,000 MT installed capacity, operating at near-full utilisation in FY25 and 6M FY26. Engro's entry in March 2025 (~15,000 MT technical-grade output) has largely displaced imports rather than directly eroding Descon's volumes. Combined domestic production now covers ~60% of estimated demand of ~100,000 MT, with imports filling the balance. Descon’s competitive durability rests on its Chematur (Sweden) technical collaboration, DCS-based automation, proximity to Punjab’s textile cluster, and 15+ years of institutional relationships across textile, mining, and food sectors, advantages a newly commissioned competitor has yet to replicate. These factors support customer retention in higher-specification segments, which carry stronger margins than commodity technical-grade products. Engro is a credible long-term competitor, leveraging port-based logistics, petrochemical integration, and southern market presence. Competitive pressure will intensify in the technical-grade segment as Engro ramps up, with the South as the primary contested geography. Descon’s edge lies in product breadth, established relationships, and northern market proximity; Engro’s in cost positioning and southern access. Sector-wide margin recovery hinges on import normalisation, correction of EFS-driven cost distortions, and demand absorption of incremental domestic supply.


Revenues

During 9MFY26, the Company reported net sales of PKR 3,697mln, reflecting a decline of ~20.2% compared to PKR 4,631mln in the corresponding period of FY25. The decline in revenue is primarily attributable to reduced selling prices amid an influx of lower-priced imports, particularly from Bangladesh, which also exerted mild pressure on domestic market share. Despite these headwinds, volumetric performance remained largely stable, indicating resilience in customer retention and market positioning. The Company sustained its sales volumes and continued to serve its core customer base, reflecting the strength of its long-standing relationships and distribution network.

On a full-year basis, FY25 revenues stood at PKR 5,999mln (FY24: PKR 5,738mln), reflecting a modest recovery due to its sole producer status. The Company’s product mix remains concentrated in technical-grade hydrogen peroxide, while food-grade HPO, though a higher-value segment, currently contributes a relatively small share to overall revenues. Export revenues have shown gradual improvement, reaching PKR 325mln in 9MFY26 (FY25: PKR 305mln), supported by the Company’s expanding international footprint, including trading operations in the UAE. While exports remain a relatively small proportion of total sales, they provide an avenue for diversification and partial insulation from domestic pricing pressures.

Revenue composition continues to be skewed toward the domestic market, which accounts for ~91% of net revenues, with exports contributing ~8.8% in 9MFY26. The Company’s demand base remains concentrated in the textile sector, supplemented by exposure to food processing, mining, and select public sector entities, reflecting moderate sectoral concentration.


Margins

The Company’s profitability metrics contracted during 9MFY26, primarily reflecting adverse pricing dynamics and elevated energy costs. Gross margin declined to ~19.5%, compared to ~29.7% in FY25 (FY24: ~20.1%; FY23: ~41.0%), largely due to selling price pressure amid the influx of lower-priced imports, alongside higher feedstock costs. This compression at the gross level translated into a reduced operating margin of ~9% (FY25: ~22.2%; FY24: ~13.4%). Finance costs increased during the period, driven by higher reliance on short-term borrowings, which further weighed on bottom-line profitability. Consequently, net margin declined to ~8.6% in 9MFY26 (FY25: ~14.3%; FY23: ~20.8%), albeit remaining broadly in line with FY24 levels (~8.8%). Looking ahead, margin recovery is expected to be supported by the commissioning of a 2 MW solar power project in early 2026, which is projected to reduce power input costs by ~8%, partially offsetting energy-related pressures. Additionally, management anticipates gradual margin stabilization, supported by recent signs of price recovery toward the close of FY26.


Sustainability

Descon Oxychem’s sustainability profile reflects a company navigating a structural shift in its competitive environment while maintaining operational discipline and pursuing incremental efficiency gains. On the operational side, the Company completed its annual plant turnaround in March 2026 in 10.5 days, ahead of the planned 12-day schedule, reflecting improving maintenance protocols under its Reliability Centred Management framework, which has transitioned the plant’s maintenance culture from reactive to preventive over several years. The commissioning of a 2 MW solar power installation during FY26 is expected to reduce power input costs by approximately 8%, with a further expansion to 4 MW under consideration for the next phase. Given that energy constitutes ~20–25% of the cost of goods sold, sustained reduction in the power cost component carries meaningful margin implications and represents a credible self-help measure in an environment where selling price recovery remains uncertain. The medium-term sustainability of earnings is dependent on the operational factors including import threats through Bangladesh and Export Facilitation Scheme (EFS).

Going forward, DOL’s strategic response to the challenges centres on three axes: deepening penetration in higher-margin, non-technical-grade segments (Aseptic and Food Grade) where Engro does not currently compete; expanding the export channel through its wholly owned subsidiary, to capture regional HPO demand; and pursuing further cost optimisation through energy efficiency initiatives and process improvements. Each of these represents a rational response to the changed competitive landscape, though the pace of execution and the revenue contribution from non-technical-grade segments remain to be demonstrated at scale. Contingent liabilities, the GIDC provision of PKR 55.32mln and the contested RLNG retrospective tariff adjustment of PKR 119mln, represent manageable but unresolved exposures that add a degree of cost-side uncertainty to the medium-term earnings trajectory. Descon Oxychem’s sustainability profile is assessed as modest, underpinned by strong financial flexibility and a conservative capital structure. However, it remains sensitive to key business risk factors, particularly persistent pricing pressure from low-priced imports, especially from Bangladesh, and the impact of the EFS, which continues to affect competitive dynamics in the local market.


Financial Risk
Working capital

The Company’s working capital management remains broadly disciplined, supported by a predominantly cash-based sales model and structured procurement arrangements. However, the working capital cycle has lengthened during 9MFY26, with net working capital days increasing to ~54 days (FY25: ~41 days; FY24: ~38 days; FY23: ~15 days). This expansion is primarily driven by a buildup in inventory days, which rose to ~52 days from ~39 days in FY25. Receivables remain well-controlled at ~11–14 days, reflecting the Company’s strong cash conversion characteristics and limited credit exposure in domestic sales. On the payable side, creditor days remain relatively low at ~12 days, largely due to the nature of arrangements with key suppliers, including Descon Engineering, which constrains the Company’s ability to offset working capital requirements through extended payment terms.

The elongation in the working capital cycle has led to a notable increase in short-term borrowings, rising to PKR 919mln in 9MFY26 from PKR 114mln in FY25. This increase is attributable to a combination of (i) strategic inventory buildup in anticipation of potential supply chain disruptions in early 2026, and (ii) relatively slower inventory turnover amid subdued demand conditions during a period of cyclical price weakness. Overall, while working capital intensity has increased compared to earlier periods, the Company has maintained operational control over receivables and inventory management. The recent normalization in the cycle between FY24 and 9MFY26 indicates a measured response to external pressures, albeit with increased reliance on short-term funding to support higher inventory levels.


Coverages

Assessment | Nishat Hotels and Properties Ltd

The Company’s cash flow generation and coverage profile remained adequate during 9MFY26, albeit reflecting moderation in line with margin compression. Free Cash Flow from Operations (FCFO) stood at PKR 314mln in 9MFY26, compared to PKR 1,419mln in FY25, primarily due to lower profitability during the period. Coverage indicators, while normalizing from the exceptionally elevated levels observed in FY25, remain strong. The interest coverage ratio stood at ~21.1x in 9MFY26 (FY25: ~392.0x; FY24: ~8.0x), indicating sufficient headroom to service finance costs. Similarly, the core coverage ratio was recorded at ~9.0x (FY25: ~46.5x; FY24: ~2.8x), reflecting continued strength in debt servicing capacity despite lower cash generation. The Company’s moderately-leveraged capital structure remains a key support factor, ensuring that reduced cash flows do not materially impair its ability to meet financial obligations. Overall, coverage metrics continue to reflect an adequate financial risk profile, with adequate buffers against earnings volatility amid prevailing competitive and cost pressures.

 

Assessment | Nishat Hotels and Propertie<span>equate during 9MFY26, albeit reflecting moderation in line with margin compression. Free Cash Flow from Operations (FCFO) stood at PKR 314mln in 9MFY26, compared to PKR 1,419mln in FY25, primarily due to lower profitability during the period. Coverage indicators, while normalizing from the exceptionally elevated levels observed in FY25, remain strong. The interest coverage ratio stood at ~21.1x in 9MFY26 (FY25: ~392.0x; FY24: ~8.0x), indicating sufficient headroom to service finance costs. Similarly, the core coverage ratio was recorded at ~9.0x (FY25: ~46.5x; FY24: ~2.8x), reflecting continued strength in debt servicing capacity despite lower cash generation. The Company’s moderately-leveraged capital structure remains a key support factor, ensuring that reduced cash flows do not materially impair its ability to meet financial obligations. Overall, coverage metrics continue to reflect an adequate financial risk profile, with adequate buffers against earnings volatility amid prevailing competitive and cost pressures.</span>



Capitalization

Assessment | Nishat Hotels and Properties Ltd

The Company’s capital structure remained conservative over FY25–FY23, with leveraging ratios of ~5.9%, ~3.8%, and ~8.2%, respectively, reflecting limited reliance on debt funding. However, during 9MFY26, leverage increased due to a rise in short-term borrowings, which grew to PKR 919mln from PKR 114mln in FY25, primarily to support higher working capital requirements. This increase is largely attributable to strategic inventory buildup ahead of anticipated geopolitical supply chain disruptions in early 2026. As a result, the debt mix has shifted toward short-term funding, with short-term borrowings now constituting ~92.1% of total debt, compared to ~53.5% in prior periods. Total debt comprises a combination of the residual long-term facility and working capital lines. While this transition reflects a move toward a moderately geared profile, overall leverage remains manageable. The higher reliance on short-term debt introduces some refinancing and liquidity considerations; however, the Company’s historically low leverage and strong coverage indicators provide adequate financial flexibility. 


 
 

May-26

www.pacra.com


(PKR mln)


Mar-26
9M
Jun-25
12M
Jun-24
12M
Jun-23
12M
A. BALANCE SHEET
1. Non-Current Assets 2,318 2,168 2,034 2,349
2. Investments 563 717 140 897
3. Related Party Exposure 0 0 0 2
4. Current Assets 2,019 1,796 1,973 1,788
a. Inventories 761 654 631 717
b. Trade Receivables 185 189 176 166
5. Total Assets 4,900 4,681 4,147 5,036
6. Current Liabilities 798 960 601 1,506
a. Trade Payables 152 172 129 364
7. Borrowings 998 213 126 273
8. Related Party Exposure 0 0 0 0
9. Non-Current Liabilities 112 132 204 192
10. Net Assets 2,992 3,376 3,216 3,065
11. Shareholders' Equity 2,992 3,376 3,216 3,059
B. INCOME STATEMENT
1. Sales 3,697 5,999 5,738 6,721
a. Cost of Good Sold (2,974) (4,220) (4,584) (3,965)
2. Gross Profit 722 1,779 1,154 2,756
a. Operating Expenses (390) (445) (384) (383)
3. Operating Profit 332 1,334 770 2,373
a. Non Operating Income or (Expense) 96 (15) 108 (123)
4. Profit or (Loss) before Interest and Tax 428 1,319 878 2,250
a. Total Finance Cost (41) (10) (24) (26)
b. Taxation (69) (449) (347) (823)
6. Net Income Or (Loss) 318 860 507 1,401
C. CASH FLOW STATEMENT
a. Free Cash Flows from Operations (FCFO) 314 1,419 127 2,374
b. Net Cash from Operating Activities before Working Capital Changes 293 1,409 107 2,345
c. Changes in Working Capital (298) 154 (132) (474)
1. Net Cash provided by Operating Activities (5) 1,563 (24) 1,871
2. Net Cash (Used in) or Available From Investing Activities (177) (1,077) 748 (905)
3. Net Cash (Used in) or Available From Financing Activities 87 (605) (511) (824)
4. Net Cash generated or (Used) during the period (95) (119) 213 142
D. RATIO ANALYSIS
1. Performance
a. Sales Growth (for the period) -17.8% 4.5% -14.6% 58.1%
b. Gross Profit Margin 19.5% 29.7% 20.1% 41.0%
c. Net Profit Margin 8.6% 14.3% 8.8% 20.8%
d. Cash Conversion Efficiency (FCFO adjusted for Working Capital/Sales) 0.4% 26.2% -0.1% 28.3%
e. Return on Equity [ Net Profit Margin * Asset Turnover * (Total Assets/Shareholders' Equity )] 13.3% 26.1% 16.2% 51.7%
2. Working Capital Management
a. Gross Working Capital (Average Days) 66 50 54 37
b. Net Working Capital (Average Days) 54 41 38 15
c. Current Ratio (Current Assets / Current Liabilities) 2.5 1.9 3.3 1.2
3. Coverages
a. EBITDA / Finance Cost 42.3 470.4 70.8 235.1
b. FCFO / Finance Cost+CMLTB+Excess STB 9.0 46.5 2.8 38.0
c. Debt Payback (Total Borrowings+Excess STB) / (FCFO-Finance Cost) 0.2 0.1 1.1 0.1
4. Capital Structure
a. Total Borrowings / (Total Borrowings+Shareholders' Equity) 25.0% 5.9% 3.8% 8.2%
b. Interest or Markup Payable (Days) 392.4 99.8 28.4 10.7
c. Entity Average Borrowing Rate 4.1% 2.3% 7.5% 3.6%

May-26

www.pacra.com

May-26

www.pacra.com

  1. Rating Team Statements
    1. Rating is just an opinion about the creditworthiness of the entity and does not constitute a recommendation to buy, hold, or sell any security of the entity rated or to buy, hold, or sell the security rated, as the case may be. (Chapter III; 14-3-(x))
    2. Conflict of Interest
      1. The Rating Team or any of their family members have no interest in this rating (Chapter III; 12-2-(j))
      2. PACRA, the analysts involved in the rating process, and members of its rating committee and their family members do not have any conflict of interest relating to the rating done by them (Chapter III; 12-2-(e) & (k))
      3. The analyst is not a substantial shareholder of the customer being rated by PACRA [Annexure F; d-(ii)]
      4. Explanation: for the purpose of the above clause, the term "family members" shall include only those family members who are dependent on the analyst and members of the rating committee.
  2. Restrictions
    1. No director, officer, or employee of PACRA communicates the information acquired by him for use for rating purposes to any other person, except where required under law to do so. (Chapter III; 10-(5))
    2. PACRA does not disclose or discuss with outside parties or make improper use of the non-public information which has come to its knowledge during a business relationship with the customer. (Chapter III; 10-7-(d))
    3. PACRA does not make proposals or recommendations regarding the activities of rated entities that could impact a credit rating of the entity subject to rating. (Chapter III; 10-7-(k))
  3. Conduct of Business
    1. PACRA fulfills its obligations in a fair, efficient, transparent, and ethical manner and renders high standards of services in performing its functions and obligations. (Chapter III; 11-A-(a))
    2. PACRA uses due care in the preparation of this Rating Report. Our information has been obtained from sources we consider to be reliable, but its accuracy or completeness is not guaranteed. PACRA does not, in every instance, independently verify or validate information received in the rating process or in preparing this Rating Report. (Clause 11-(A)(p))
    3. PACRA prohibits its employees and analysts from soliciting money, gifts, or favors from anyone with whom PACRA conducts business. (Chapter III; 11-A-(q))
    4. PACRA ensures before the commencement of the rating process that an analyst or employee has not had a recent employment or other significant business or personal relationship with the rated entity that may cause or may be perceived as causing a conflict of interest. (Chapter III; 11-A-(r))
    5. PACRA maintains the principle of integrity in seeking rating business. (Chapter III; 11-A-(u))
    6. PACRA promptly investigates in the event of misconduct or a breach of the policies, procedures, and controls, and takes appropriate steps to rectify any weaknesses to prevent any recurrence, along with suitable punitive action against the responsible employee(s). (Chapter III; 11-B-(m))
  4. Independence & Conflict of Interest
    1. PACRA receives compensation from the entity being rated or any third party for the rating services it offers. The receipt of this compensation has no influence on PACRA’s opinions or other analytical processes. In all instances, PACRA is committed to preserving the objectivity, integrity, and independence of its ratings. Our relationship is governed by two distinct mandates: i) rating mandate - signed with the entity being rated or issuer of the debt instrument, and ii) fee mandate - signed with the payer, which can be different from the entity.
    2. PACRA does not provide consultancy/advisory services or other services to any of its customers or their associated companies and associated undertakings that are being rated or have been rated by it during the preceding three years, unless it has an adequate mechanism in place ensuring that the provision of such services does not lead to a conflict of interest situation with its rating activities. (Chapter III; 12-2-(d))
    3. PACRA discloses that no shareholder directly or indirectly holding 10% or more of the share capital of PACRA also holds directly or indirectly 10% or more of the share capital of the entity which is subject to rating or the entity which issued the instrument subject to rating by PACRA. (Chapter III; 12-2-(f))
    4. PACRA ensures that the rating assigned to an entity or instrument is not affected by the existence of a business relationship between PACRA and the entity or any other party, or the non-existence of such a relationship. (Chapter III; 12-2-(i))
    5. PACRA ensures that the analysts or any of their family members shall not buy, sell, or engage in any transaction in any security which falls in the analyst’s area of primary analytical responsibility. This clause, however, does not apply to investments in securities through collective investment schemes. (Chapter III; 12-2-(l))
    6. PACRA has established policies and procedures governing investments and trading in securities by its employees and for monitoring the same to prevent insider trading, market manipulation, or any other market abuse. (Chapter III; 11-B-(g))
  5. Monitoring and Review
    1. PACRA monitors all the outstanding ratings continuously, and any potential change therein due to any event associated with the issuer, the security arrangement, the industry, etc., is disseminated to the market immediately and in an effective manner after appropriate consultation with the entity/issuer. (Chapter III; 17-(a))
    2. PACRA reviews all the outstanding ratings periodically on an annual basis. Provided that public dissemination of annual review and in an instance of change in rating will be made. (Chapter III; 17-(b))
    3. PACRA initiates an immediate review of the outstanding rating upon becoming aware of any information that may reasonably be expected to result in downgrading of the rating. (Chapter III; 17-(c))
    4. PACRA engages with the issuer and the debt securities trustee to remain updated on all information pertaining to the rating of the entity/instrument. (Chapter III; 17-(d))
  6. Probability of Default
    1. PACRA’s Rating Scale reflects the expectation of credit risk. The highest rating has the lowest relative likelihood of default (i.e., probability). PACRA’s transition studies capture the historical performance behavior of a specific rating notch. Transition behavior of the assigned rating can be obtained from PACRA’s Transition Study available at our website. (www.pacra.com) However, the actual transition of rating may not follow the pattern observed in the past. (Chapter III; 14-3(f)(vii))
  7. Proprietary Information
    1. All information contained herein is considered proprietary by PACRA. Hence, none of the information in this document can be copied or otherwise reproduced, stored, or disseminated in whole or in part in any form or by any means whatsoever by any person without PACRA’s prior written consent.

May-26

www.pacra.com